प्लिसनटन, कैलिफ़ोर्निया, मार्च 15, 2024 (ग्लोब न्यूज़वायर) — प्रोसोम्नस, इंक. (NASDAQ: ओएसए) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today it has postponed the release of its 2023 fourth quarter and full year financial results and the related investor conference call. The rescheduled call will be held after market close on Tuesday, March 26, 2024 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Registration and dial-in information can be found on the investor relations website. Additionally, the Company will not be attending the Roth Conference.
ProSomnus के बारे में
ProSomnus (NASDAQ: ओएसए) is the leading non-CPAP therapy for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion people worldwide, that is associated with comorbidities including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. Non-invasive, patient preferred and easy to use, ProSomnus devices have demonstrated excellent efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. ProSomnus precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, TRICARE and many Government-sponsored healthcare plans around the world, representing over 200 million covered lives. To learn more, visit www.proSomnus.com.
निवेशक संपर्क करें
माइक कैवानुघ
आईसीआर वेस्टविक
फोन: + 1.617.877.9641
ईमेल माइक.कवानुघ @westwicke.com
मीडिया संपर्क
Heather Whalen
प्रोसोम्नस
फोन: + 1.925.360.2990
ईमेल HWhalen@ProSomnus.com
- एसईओ संचालित सामग्री और पीआर वितरण। आज ही प्रवर्धित हो जाओ।
- प्लेटोडेटा.नेटवर्क वर्टिकल जेनरेटिव एआई। स्वयं को शक्तिवान बनाएं। यहां पहुंचें।
- प्लेटोआईस्ट्रीम। Web3 इंटेलिजेंस। ज्ञान प्रवर्धित। यहां पहुंचें।
- प्लेटोईएसजी. कार्बन, क्लीनटेक, ऊर्जा, पर्यावरण, सौर, कचरा प्रबंधन। यहां पहुंचें।
- प्लेटोहेल्थ। बायोटेक और क्लिनिकल परीक्षण इंटेलिजेंस। यहां पहुंचें।
- स्रोत: https://www.biospace.com/article/releases/prosomnus-reschedules-fourth-quarter-and-fiscal-year-2023-investor-and-business-update-call/?s=93
